188 related articles for article (PubMed ID: 7549499)
21. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
22. Histamine release from human colonic mucosa in response to anti-IgE.
Hörauf AM; Matek M; Raithel M; Baenkler HW
Agents Actions; 1989 Apr; 27(1-2):89-92. PubMed ID: 2473643
[TBL] [Abstract][Full Text] [Related]
23. Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.
Ligumsky M; Simon PL; Karmeli F; Rachmilewitz D
Gut; 1990 Jun; 31(6):686-9. PubMed ID: 2379873
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.
Tavano F; Palmieri O; di Mola FF; Latiano A; Burbaci FP; Valvano MR; Corritore G; Augello B; Merla G; Annese V; Andriulli A; di Sebastiano P
Dig Liver Dis; 2013 Dec; 45(12):1003-10. PubMed ID: 23827863
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.
Monajemi H; Meenan J; Lamping R; Obradov DO; Radema SA; Trown PW; Tytgat GN; Van Deventer SJ
Gastroenterology; 1996 Mar; 110(3):733-9. PubMed ID: 8608882
[TBL] [Abstract][Full Text] [Related]
27. The role of interferon gamma in the pathogenesis of Crohn's disease.
Sasaki T; Hiwatashi N; Yamazaki H; Noguchi M; Toyota T
Gastroenterol Jpn; 1992 Feb; 27(1):29-36. PubMed ID: 1555746
[TBL] [Abstract][Full Text] [Related]
28.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
29. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
Peskar BM; Dreyling KW; Peskar BA; May B; Goebell H
Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
31. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid receptor expression in inflammatory bowel disease: evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis.
Raddatz D; Middel P; Bockemühl M; Benöhr P; Wissmann C; Schwörer H; Ramadori G
Aliment Pharmacol Ther; 2004 Jan; 19(1):47-61. PubMed ID: 14687166
[TBL] [Abstract][Full Text] [Related]
33. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
34. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
[TBL] [Abstract][Full Text] [Related]
35. Substrate utilization by intestinal mucosal tissue strips from patients with inflammatory bowel disease.
Jørgensen J; Mortensen PB
Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G405-11. PubMed ID: 11447021
[TBL] [Abstract][Full Text] [Related]
36. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
37. The immuno-inflammatory reaction in Crohn's disease and ulcerative colitis: characterisation, genetics and clinical application. Focus on TNF alpha.
Louis E
Acta Gastroenterol Belg; 2001; 64(1):1-5. PubMed ID: 11322060
[TBL] [Abstract][Full Text] [Related]
38. Alterations in mucosal content of colonic glycoconjugates in inflammatory bowel disease defined by monoclonal antibodies.
Podolsky DK; Fournier DA
Gastroenterology; 1988 Aug; 95(2):379-87. PubMed ID: 3292335
[TBL] [Abstract][Full Text] [Related]
39. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease.
Tysk C; Riedesel H; Lindberg E; Panzini B; Podolsky D; Järnerot G
Gastroenterology; 1991 Feb; 100(2):419-23. PubMed ID: 1985038
[TBL] [Abstract][Full Text] [Related]
40. Definition and evaluation of mucosal healing in clinical practice.
Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
